ATLASPalvella Therapeutics (PVLA) earnings date: Nov 5, 2026
Palvella Therapeutics (PVLA) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026 (confirmed), before the open. Analysts expect EPS of -$1.73. Free email alerts for this report are just below.
Source: company filings and exchange data · Updated Nov 3, 2026
ATLAS view on PVLA
| Last price | $152.05 (+3.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.7% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Palvella Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Get an email before and after Palvella Therapeutics reports, free with your ATLAS account
Earnings alerts are a free benefit of your ATLAS account. The company goes to your watchlist and we email you when it reports. Google signup is one click.
Create free accountPVLA earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$1.73 |
| Last report | Aug 4, 2026 · Miss |
| Beat rate (last 4 reports) | 1 of 4 (25%) |
| Average EPS surprise | -50.4% |
| Average move around a report | ±6.9% (last 4) |
| Sector | Healthcare · Biotechnology |
Palvella Therapeutics earnings history: last 4 reports
Palvella Therapeutics last reported on Aug 4, 2026: EPS of -$1.52 against an estimate of -$1.15 (-32.2% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 4, 2026 | -$1.15 | -$1.52 | -32.2% | Miss | +10.0% |
| May 7, 2026 | -$0.93 | -$1.20 | -29.0% | Miss | -6.8% |
| Mar 24, 2026 | -$0.40 | -$1.00 | -150.0% | Miss | +2.9% |
| Jan 7, 2026 | $1.94 | $2.13 | +9.8% | Beat | +7.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for PVLA
See the fair value, the probability range and the earnings history of Palvella Therapeutics on its ATLAS page.
Palvella Therapeutics (PVLA) stock analysisPlans from €3.99 a month.
Palvella Therapeutics earnings: frequently asked questions
When does Palvella Therapeutics (PVLA) report earnings?
Palvella Therapeutics is scheduled to report on Thursday, November 5, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for PVLA?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$1.73 per share (USD). Estimates can change before the report.
How often does PVLA beat earnings estimates?
Of its last 4 reports with a recorded result, Palvella Therapeutics beat the EPS estimate 1 times; the average surprise was -50.4%. Past results do not predict the next one.
How much does PVLA move around earnings?
Over its last 4 reports the stock moved an average of 6.9% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did Palvella Therapeutics beat earnings estimates last quarter?
Palvella Therapeutics last reported on Aug 4, 2026: EPS of -$1.52 against an estimate of -$1.15 (-32.2% surprise), a miss.
How much does PVLA usually move in a day?
On a normal trading day the ATLAS model puts PVLA’s one-day range at about ±3.7%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer